ArticleCurrent genomics2025
A Novel
Article in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to conduct a comprehensive transcriptome analysis of Methodology: High-throughput Illumina sequencing was performed, generating 32.97 million clean reads from roots and 33.96 million from leaves. A 98.75% complete Results: A total of 316,613 SNPs were identified in roots and 247,967 SNPs in leaves. SSR analysis revealed 21,634 markers, with mononucleotide repeats being predominant. A total of 5,781 transcription factors (TFs) were characterized, including members of the C2H2, MYB-HB-like, and bHLH families. Differential expression analysis identified 4,643 DEGs, with flavonoid biosynthesis genes upregulated in leaves and lignin-associated genes upregulated in roots. Discussion: GO and KEGG analyses highlighted significant enrichment of metabolic and biosynthetic pathways. The medicinal benefits of Conclusion: This study provides valuable SNP and SSR markers and offers insights into the genetic mechanisms underlying the medicinal properties of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.